Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46 (8) , 720-725
Abstract
No abstract availableKeywords
Funding Information
- Ministerie van Volksgezondheid, Welzijn en Sport
- European Commission
- Erasmus Medisch Centrum
- ZonMw
- Ministerie van Onderwijs, Cultuur en Wetenschap
- Foundation for Liver Research
- Erasmus Universiteit Rotterdam
This publication has 43 references indexed in Scilit:
- Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008European Journal of Epidemiology, 2012
- Methods of data collection and definitions of cardiac outcomes in the Rotterdam StudyEuropean Journal of Epidemiology, 2012
- Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid DeregulationJournal of Lipids, 2011
- Inflammatory Concepts of ObesityInternational Journal of Inflammation, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studiesEuropean Journal of Epidemiology, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsBMJ, 2009
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998